Table 1.
Clinician’s Guide to Pi/Vitamin D Supplementation 1.
| Phosphate Preparations | Phosphorus Content | Potassium (K) Content | Sodium (Na) Content |
|---|---|---|---|
| Neutraphos-powder (for mixing with liquid) |
250 mg/packet | 270 mg/packet | 164 mg/packet |
| Neutraphos-K-powder (for mixing with liquid) |
250 mg/packet | 556 mg/packet | 0 mg/packet |
| K-Phos Original-tablet (to mix in liquid, acidifying) |
114 mg/tablet | 144 mg/tablet | 0 mg/tablet |
| K-Phos MF-tablet (mixing not required, acidifying) |
126 mg/tablet | 45 mg/tablet | 67 mg/tablet |
| K-Phos #2 (double strength of K-Phos MF) |
250 mg/tablet | 90 mg/tablet | 133 mg/tablet |
| K-Phos Neutral-tablet (non-acidifying, mixing not required) |
250 mg/tablet | 45 mg/tablet | 298 mg/tablet |
| Phospha-Soda-solution (small doses may be given undiluted) |
127 mg/mL | 0 mg/mL | 152 mg/mL |
| Joulie’s solution (prepared by compounding pharmacies) |
30 mg/mL | 0 mg/mL | 17.5–20 mg/mL |
| Vitamin D and Related Agents | Agent | Available Preparations | |
| Vitamin D | Calciferol (Drisdol) | Solution: 8000 IU/mL Tablets: 25,000 and 50,000 IU |
|
| Dihydrotachysterol | DHT (Hytakerol) | Solution: 0.2 µg/5 mL Tablets: 0.125, 0.2, and 0.4 mg |
|
| 1,25 dihydroxyvitamin D | Calcitriol (Rocaltrol) | 0.25 and 0.5 µg capsules and 1 µg/mL solution | |
| Calcijex | Ampules for IV use containing 1 or 2 µg of drug per mL | ||
| 1α-hydroxyvitamin D | Alfacalcidol | 0.25, 0.5, and 1 µg capsules Oral solution (drops): 2 µg/mL Solution for IV use: 2 µg/mL |
|
| Vitamin D analogs | Paricalcitol (Zemplar) | 1, 2, and 4 µg capsules | |
| Doxercalciferol (Hectoral) | 0.5, 1, and 2.5 µg capsules | ||
1 SI conversion: 1 mg phosphorus = 0.32 mmol phosphorus, 1 µg vitamin D = 40 IU vitamin D. IU, international unit. IV, intravenous. From: [102].